Drugs / Myeloma Immunoglobulin Idiotype Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00006184 | Feb 2001 → Jan 2008 | plasma cell myeloma | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Myeloma Immunoglobulin Idiotype Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00006184 ↗ |
| Modality | Vaccine | “Donors would be immunized with an Id vaccine prepared from the patient.” NCT00006184 ↗ |
| Route | Subcutaneous | “3 subcutaneous (SC) injections of myeloma protein within 10 weeks before stem cell collection” NCT00006184 ↗ |